Press Releases Ypsomed Group

Burgdorf - Ypsomed is pleased to announce that it has granted to a major, globally acting pharmaceutical company a non exclusive license to use certain patents, which protect inventions of Ypsomed in the area of autoinjector technology. Ypsomed expects to receive several million Swiss Francs in license fees over the term of the concluded agreement.

Go Back